The long term prognostic significance of c-erbB-2 in primary breast cancer - Wikidata - awgldk - TriplyDB

The long term prognostic significance of c-erbB-2 in primary breast cancer

The long term prognostic significance of c-erbB-2 in primary breast cancer

http://www.wikidata.org/entity/Q35983210

about

The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer Amplification of fgfr4 gene in human breast and gynecological cancers HER2 testing: a review of detection methodologies and their clinical performance Molecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53 Role of HER2 gene overexpression in breast carcinoma.Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancer HER2: the neu prognostic marker for breast cancer.The epidermal growth factor receptor family in breast cancer.Testing for HER2 in Breast Cancer: A Continuing Evolution.Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer.The significance of immunohistochemistry in the diagnosis and therapy of neoplasms.Predictive and prognostic markers for invasive breast cancer.Trastuzumab-associated cardiotoxicity.Image analysis and morphometry in the diagnosis of breast cancer.The role of HER-2 in Breast Cancer Statistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers.HER2 in solid tumors: more than 10 years under the microscope; where are we now?Retrospective analysis of metastatic behaviour of breast cancer subtypes Clinical significance of erbB-2 (HER-2/neu) protein.The polymerase chain reaction: its use in the molecular characterization and diagnosis of cancers.IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma.Prognostic significance of HER-2 status in women with inflammatory breast cancer Targeted therapy in breast cancer: the HER-2/neu gene and protein.Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats.Prognostic significance of cathepsin-D in patients with breast cancer Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease.c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis.Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma.Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.Personalized medicine in breast cancer: a systematic review.c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.c-erbB-2 is not a major factor in the development of colorectal cancer Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer.Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.Recent perspectives of breast cancer prognosis and predictive factors.Prognostic association of c-erbB-2 oncogene amplification and protein overexpression in human breast cancer using archival tissues. A comparative study.Targeting HER2 in Advanced Breast Cancer.HER2-positive early breast cancer and trastuzumab: a surgeon's perspective.

P2860

Q24644189-C7FB359B-ABAB-43EA-8864-435764AFF94E Q24795406-B12AD0A0-7F1E-4C70-8BA6-3976E3F8B61D Q28249028-BBAF1A52-449F-4B6E-BEC1-131F95EBE6AE Q28280488-28DB6389-0EEE-4A73-B942-C81ED4090912 Q28363615-FE2E4771-8B37-47C3-B545-DFBA4BB9BE1B Q33810080-83884D4A-DD0B-4836-87F1-21A885204EFE Q33882536-84C9C56E-FFE0-4807-9437-4A0B4D9500AD Q34248406-B55BC9D1-7559-4D8A-ADC2-F8EBC29754E3 Q34363400-061196A9-1471-4697-9BEF-F88CCF7642FD Q34424285-A9A09C33-61F2-4613-9EFE-BF09E2C39354 Q34548277-7DDD35B7-0062-482D-8386-11C2D05C6889 Q34602545-0FD731A2-59AB-4927-8283-34E199CBFDE9 Q34612314-A2AE6355-A6E7-4791-BCF1-C4827F5CC49F Q34867708-4ED9F8E2-5DDC-4744-A1E2-6174A39ABBC3 Q34954877-765068D3-E557-4722-8769-FB66AD675855 Q35068343-06FDDF56-651D-40AB-A26B-5B764234A94B Q35168065-DD0E4179-EFDB-4528-A141-82D60460437D Q35211263-0B8E8037-9219-44DA-87ED-B22989D1D5C6 Q35252752-1EA7F916-228B-465D-B085-56BC6B96EF1E Q35269163-EC74AD0C-A47B-4C1F-BE7C-74018CBA1CBB Q35367235-CB37C820-D2E8-4A1B-BE3A-EF1178EED1DF Q35588768-D37B93B8-9356-4311-AEA3-F91A74429FDF Q35624765-1B2B947A-ECEF-4B3A-8852-69A8538397D7 Q35648508-C7905A54-B72C-484D-9D30-C821FE83B530 Q35787289-2FFA6B21-5B83-448E-8081-621B30E73AC2 Q35976409-F131E850-FE7D-4346-87D8-E68BCAC5A162 Q35978203-C2700D09-5896-45AB-9206-2508EE1D0EC4 Q35993223-E142D75D-9DD2-493C-9E65-1B4811475E06 Q36080594-17F10587-A0C5-453E-9C7E-98F18329C43F Q36081269-B7AC5E62-5D9B-4854-8B1F-31E2D16C77A0 Q36310182-4F3D0882-A962-450F-9FE1-E9BAF2DFE220 Q36421775-382A251E-AB20-4F8B-97B9-83DC4FBD1D37 Q36644043-22DD7EC4-F9E8-4DEA-823F-4E57ADFC2CF0 Q36696088-533C21B4-30FB-4A6C-A4A2-3C85895555D2 Q36718403-7EBD301B-0E6F-4C51-A132-D1D760962A7A Q37073633-9A1269CA-9DD3-4B54-AB4E-48CB405FE99D Q37407119-BBFCB514-D4C9-401E-9B7C-4581452678BD Q38484552-0FEECF77-A7A6-4479-B08F-2FDBC43083EF Q38632768-4CEE1E38-18F4-4476-921C-9D3402C6CCEA Q40105055-69A3FC36-E1C7-4191-A3E4-6619219B10EF

P2860

The long term prognostic significance of c-erbB-2 in primary breast cancer

http://www.wikidata.org/entity/Q35983210

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

The long term prognostic significance of c-erbB-2 in primary breast cancer

@ast

The long term prognostic significance of c-erbB-2 in primary breast cancer

@en

type

label

The long term prognostic significance of c-erbB-2 in primary breast cancer

@ast

The long term prognostic significance of c-erbB-2 in primary breast cancer

@en

prefLabel

The long term prognostic significance of c-erbB-2 in primary breast cancer

@ast

The long term prognostic significance of c-erbB-2 in primary breast cancer

@en

P1433

Q35983210-402E3EA1-11ED-4EAA-9901-143386824D47

P1476

Q35983210-DC3120AC-5C87-49FB-8EB2-5911EA3ACD5A

P2093

Q35983210-11476902-A930-456D-AC89-963540B81A08

Q35983210-2C7A3D33-D75C-4354-8778-31F33DE28DEA

Q35983210-8D05F36F-F2E6-4BFA-9084-6063D12E2AEA

Q35983210-9B5937A8-7836-45D0-87A5-2CE31ED1BE0D

Q35983210-A80762A1-8785-4A89-8207-18CA2C7DA3FD

Q35983210-B8427CD3-FFA6-41F0-948A-53AADC3DE7BA

Q35983210-BFB957CF-28C3-4F09-9FB9-32639332ED1D

Q35983210-C90C653F-47FA-403F-9995-5B8CF506FB80

Q35983210-DBF3013D-3887-414C-82FE-E6D6210639FE

Q35983210-E4E23FB0-6068-4E59-80DC-91712A16BE7D

P2860

Q35983210-02191292-57EC-4A54-BCF7-9D545283023B

Q35983210-0249AF49-006F-4CD4-B20E-7D223292638E

Q35983210-0635A112-A6AA-47DB-8D74-030F31FB1B59

Q35983210-39AE14FD-0AAA-4E6B-8177-0E3DB6DEB0EF

Q35983210-3A3672C7-380D-4B7F-93D1-7E0C6B094AB8

Q35983210-3BDA8F9A-ECD0-48AA-B3A8-4D309834BCD1

Q35983210-4BC4CE6B-8D85-421C-AB9A-85D3EB753EF6

Q35983210-81FD1445-274F-41B4-95B2-E2B6B4F839C1

Q35983210-8CE4E966-EDCB-4017-98DF-792772AEF0EB

Q35983210-ABF2A119-DBBE-401A-BB79-E9D08E444918

P2888

Q35983210-BF83BAE5-5169-4C78-96FB-AB06AA556F59

P304

Q35983210-9F239407-6EC1-4E32-9B84-F65C56EC1B1B

P31

Q35983210-2E081EF9-CED3-4340-A34F-A3A454DE86D1

P356

Q35983210-CFF2A7B5-7D48-4913-A691-F74719AE8459

P407

Q35983210-413DF3F5-77E1-470E-9A35-27CDCD72DC5E

P433

Q35983210-98DFD5C7-C739-4E1A-865C-D4E221D48541

P478

Q35983210-098556F2-7BC4-4045-AF60-FCE3C74427B9

P577

Q35983210-AE48D0FC-94D3-4675-95D5-EFB9C9AB9864

P5875

Q35983210-E034EF41-3B17-4958-9F0E-901D911932B7

P698

Q35983210-0C370D33-3BB2-4D3E-850F-CD9F323C4AA0

P932

Q35983210-0EEC53E2-7437-4703-B53D-76372EE2BF6E

P356

P1433

British Journal of Cancer

P1476

The long term prognostic significance of c-erbB-2 in primary breast cancer

@en

P2093

Barraclough BR

http://www.w3.org/2001/XMLSchema#string

Cooke T

http://www.w3.org/2001/XMLSchema#string

George WD

http://www.w3.org/2001/XMLSchema#string

Holt S

http://www.w3.org/2001/XMLSchema#string

Murray GD

http://www.w3.org/2001/XMLSchema#string

Myskov M

http://www.w3.org/2001/XMLSchema#string

Platt-Higgins A

http://www.w3.org/2001/XMLSchema#string

Rudland PS

http://www.w3.org/2001/XMLSchema#string

Spedding A

http://www.w3.org/2001/XMLSchema#string

Winstanley J

http://www.w3.org/2001/XMLSchema#string

P2860

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene

Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms

Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading.

c-erbB-2 expression in benign and malignant breast disease

An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma

p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.

Oestrogen receptors and prognosis in early breast cancer.

Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.

Pattern of expression of c-erbB-2 oncoprotein in human fetuses.

P2888

P304

447-450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BJC.1991.103

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

63

http://www.w3.org/2001/XMLSchema#string

P577

1991-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21484020

http://www.w3.org/2001/XMLSchema#string

P698

1672256

http://www.w3.org/2001/XMLSchema#string

P932

1971845

http://www.w3.org/2001/XMLSchema#string